Review of economic evidence in the prevention and early detection of colorectal cancer
- PMID: 24229442
- PMCID: PMC3847082
- DOI: 10.1186/2191-1991-3-20
Review of economic evidence in the prevention and early detection of colorectal cancer
Abstract
This paper aims to systematically review the cost-effectiveness evidence, and to provide a critical appraisal of the methods used in the model-based economic evaluation of CRC screening and subsequent surveillance. A search strategy was developed to capture relevant evidence published 1999-November 2012. Databases searched were MEDLINE, EMBASE, National Health Service Economic Evaluation (NHS EED), EconLit, and HTA. Full economic evaluations that considered costs and health outcomes of relevant intervention were included. Sixty-eight studies which used either cohort simulation or individual-level simulation were included. Follow-up strategies were mostly embedded in the screening model. Approximately 195 comparisons were made across different modalities; however, strategies modelled were often simplified due to insufficient evidence and comparators chosen insufficiently reflected current practice/recommendations. Studies used up-to-date evidence on the diagnostic test performance combined with outdated information on CRC treatments. Quality of life relating to follow-up surveillance is rare. Quality of life relating to CRC disease states was largely taken from a single study. Some studies omitted to say how identified adenomas or CRC were managed. Besides deterministic sensitivity analysis, probabilistic sensitivity analysis (PSA) was undertaken in some studies, but the distributions used for PSA were rarely reported or justified. The cost-effectiveness of follow-up strategies among people with confirmed adenomas are warranted in aiding evidence-informed decision making in response to the rapidly evolving technologies and rising expectations.
Figures


Similar articles
-
Chemoprevention of colorectal cancer: systematic review and economic evaluation.Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Health Technol Assess. 2010. PMID: 20594533 Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
-
Sutureless Aortic Valve Replacement for Treatment of Severe Aortic Stenosis: A Single Technology Assessment of Perceval Sutureless Aortic Valve [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 25. Report from the Norwegian Institute of Public Health No. 2017-01. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 25. Report from the Norwegian Institute of Public Health No. 2017-01. PMID: 29553663 Free Books & Documents. Review.
-
Screening for Colorectal Cancer: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-1. PMID: 34097369 Free Books & Documents. Review.
Cited by
-
Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.PLoS One. 2014 Oct 23;9(10):e111260. doi: 10.1371/journal.pone.0111260. eCollection 2014. PLoS One. 2014. PMID: 25340858 Free PMC article.
-
Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria.BMC Gastroenterol. 2019 Dec 5;19(1):209. doi: 10.1186/s12876-019-1121-y. BMC Gastroenterol. 2019. PMID: 31805871 Free PMC article.
-
Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada.Curr Oncol. 2015 Apr;22(2):e41-50. doi: 10.3747/co.22.2013. Curr Oncol. 2015. PMID: 25908920 Free PMC article.
-
Knowledge and practice of colorectal screening in a suburban group of Iraqi American women.J Cancer Educ. 2015 Jun;30(2):284-93. doi: 10.1007/s13187-015-0813-4. J Cancer Educ. 2015. PMID: 25787223 Free PMC article.
-
Cancer prevention: state of the art and future prospects.J Prev Med Hyg. 2015 Jun 10;56(1):E21-7. J Prev Med Hyg. 2015. PMID: 26789828 Free PMC article. Review.
References
-
- Martinez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH, Church TR, Robertson DJ, Smith-Warner SA, Jacobs ET, Alberts DS, Greenberg ER. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009;3(3):832–841. - PMC - PubMed
-
- Winawer SJ, Zauber AG, Ho MN. et al.Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;3:658–662. - PubMed
-
- Muto T, Bussey HRJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;3:2250–2270. - PubMed
-
- Olsen AH, Lawrence W, Snook E. et al.Risk factors and screening techniques in 500 patients with benign and malignant polyps. Dis Colon Rectum. 1988;3:216–221. - PubMed
-
- Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzik J. UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;3(9726):1624–1633. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous